Oxycodone Hydrochloride Tablet
Product Images NDC 76420-762

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxycodone Hydrochloride (NDC 76420-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxy 01)

Chemical Structure (Oxy 01)
Chemical structure diagram of Oxycodone Hydrochloride, showing its molecular framework with labeled functional groups including hydroxyl, methoxy, and carbonyl groups, and the hydrochloride component.*
FDA Label Image

Figure 1 (Oxy 02)

Figure 1 (Oxy 02)
A line graph illustrating the concentration (ng/mL) of oxycodone over time (hours) for three different dosages: 5 mg x 1, 5 mg x 3, and 5 mg x 6. The graph shows concentration peaking shortly after administration and gradually declining to near zero by 25 hours.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
This image shows multiple labels for Oxycodone Hydrochloride Tablets, USP 5 mg, manufactured and packaged by Enovachem Pharmaceuticals in Torrance, CA, and relabeled by the same company. Each label displays the product name, strength (5 mg), dosage form (tablet), and varying package quantities: 10, 20, 30, 60, and 90 tablets. Labels include NDC numbers, controlled substance classification (CII), lot number, and storage instructions, with clear barcodes and QR codes for identification.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Labels for Oxycodone Hydrochloride Tablets USP 10 mg show various package quantities including 10, 20, 30, 60, and 90 tablets. Each label lists NDC codes such as 76420-757-10 and 76420-757-90, with packaging by Enovachem Pharmaceuticals and marketing by Rhodes Pharmaceuticals L.P. The labels note the drug status as Schedule CII and include storage instructions and product descriptions.*
FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

Principal Display Panel (15 mg Tablet Bottle Label)
Multiple packaging labels for Oxycodone Hydrochloride Tablets, USP 15 mg by Enovachem Pharmaceuticals. Labels indicate quantities of 10, 20, 30, 60, 90, and 100 tablets. Each label displays NDC numbers, lot, expiration, drug status (CII), and storage instructions. Marketed by Rhodes Pharmaceuticals L.P., with tablet description as white to off-white oval tablets, debossed and scored.*
FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Principal Display Panel (20 mg Tablet Bottle Label)
Labels for Oxycodone Hydrochloride Tablets USP 20 mg show packaging information for quantities of 10, 20, 30, 60, 90, and 100 tablets. The labels include the product name, NDC numbers, and drug status as Schedule II (CII). Labeling indicates packaging and marketing details by Enovachem Pharmaceuticals and Rhodes Pharmaceuticals L.P., with caution notes on prescription requirements and storage conditions. Each label contains QR codes and barcodes for identification.*
FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Principal Display Panel (30 mg Tablet Bottle Label)
Labels for Oxycodone Hydrochloride Tablets, USP 30 mg, packaged by Enovachem Pharmaceuticals, Torrance, CA. The labels show different package quantities: 10, 20, 30, 60, 90, and 100 tablets. Marketed by Rhodes Pharmaceuticals L.P. The labels include NDC codes for each quantity and indicate Schedule II drug status (CII). The tablets are described as white to off-white, round, biconvex, debossed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.